Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and Management of Pouchitis and Ileoanal Pouch Dysfunction

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the surgical treatment of choice for patients with medically refractory ulcerative colitis (UC) or UC with dysplasia and for the majority of patients with familial adenomatous polyposis. However, UC patients with IPAA are susceptible to inflammatory and noninflammatory sequelae, such as pouchitis, Crohn’s disease of the pouch, cuffitis, and irritable pouch syndrome, in addition to common surgery-associated complications, which adversely affect the surgical outcome and compromise health-related quality of life. Pouchitis is the most frequent long-term complication of IPAA in patients with UC, with a cumulative prevalence of up to 50%. Pouchitis may be classified based on the etiology into idiopathic and secondary types, and the management is often different. Pouchoscopy is the most important tool for the diagnosis and differential diagnosis in patients with pouch dysfunction. Antibiotic therapy is the mainstay of treatment for active pouchitis. Some patients may develop dependency on antibiotics, requiring long-term maintenance therapy. Although management of antibiotic-dependent or antibiotic-refractory pouchitis has been challenging, secondary etiology for pouchitis should be evaluated and modified, if possible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fazio VW, Ziv Y, Church JM, et al.: Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg 1995, 222:120–127.

    Article  CAS  PubMed  Google Scholar 

  2. Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994, 107:1856–1860.

    CAS  PubMed  Google Scholar 

  3. Coffey JC, Winter DC, Neary P, et al.: Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 2002, 45:30–38.

    CAS  PubMed  Google Scholar 

  4. Stocchi L, Pemberton JH: Pouch and pouchitis. Gastroenterol Clin North Am 2001, 30:223–241.

    Article  CAS  PubMed  Google Scholar 

  5. Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131:497–500; discussion 501–502.

    CAS  PubMed  Google Scholar 

  6. Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.

    Article  PubMed  Google Scholar 

  7. Gosselink MP, Schouten WR, van Lieshout LM, et al.: Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004, 47:1519–1525.

    Article  PubMed  Google Scholar 

  8. Ohge H, Furne JK, Springfield J, et al.: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005, 48:469–475.

    Article  PubMed  Google Scholar 

  9. Falk A, Olsson C, Ahrne S, et al.: Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007, 42:973–985.

    Article  CAS  PubMed  Google Scholar 

  10. •• Komanduri S, Gillevet PM, Sikaroodi M, et al.: Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007, 5:352–360. This article describes a comprehensive study of microbiota using 16sRNA-based molecular microbiology in pouchitis patients.

    Article  CAS  PubMed  Google Scholar 

  11. McLaughlin SD, Walker AW, Churcher C, et al.: The bacteriology of pouchitis: a molecular phylogenetic analysis using 16 S rRNA gene cloning and sequencing [abstract]. Available at http://www.broadmedical.org/about/annual_meetings/2010/Abstract-McLaughlin.html. Accessed August 2010.

  12. Ottesen EA, Hong JW, Quake SR, et al.: Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 2006, 314:1464–1467.

    Article  CAS  PubMed  Google Scholar 

  13. Liu WT, Zhu L: Environmental microbiology-on-a-chip and its future impacts. Trends Biotechnol 2005, 23:174–179.

    Article  CAS  PubMed  Google Scholar 

  14. Marcy Y, Ouverney C, Bik EM, et al.: Dissecting biological “dark matter” with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Natl Acad Sci U S A 2007, 104:11889–11894.

    Article  CAS  PubMed  Google Scholar 

  15. •• Turroni S, Vitali B, Candela M, et al.: Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol 2010, 16:30–41. This article describes the first study to investigate the role of proteomics in chronic pouchitis.

    CAS  PubMed  Google Scholar 

  16. Kroesen AJ, Leistenschneider P, Lehmann K, et al.: Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis 2006, 12:736–744.

    Article  PubMed  Google Scholar 

  17. DeSilva HJ, Jones M, Prince C, et al.: Lymphocyte and macrophage subpopulations in pelvic ileal reservoirs. Gut 1991, 32:1160–1165.

    Article  CAS  Google Scholar 

  18. Hirata I, Berrebi G, Austin LL, et al.: Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 1986, 31:593–603.

    Article  CAS  PubMed  Google Scholar 

  19. • Navaneethan U, Shen B: Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010, 105:51–64. This article presents a comprehensive review of the various causes of secondary pouchitis.

    Article  PubMed  Google Scholar 

  20. Casadesus D, Tani T, Wakai T, et al.: Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. World J Gastroenterol 2007, 13:1085–1089.

    CAS  PubMed  Google Scholar 

  21. •• Shen B, Jiang ZD, Fazio VW, et al.: Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:782–788. This article describes a very important study showing that C. difficile infection not only can occur in patients without a colon, but also can be common.

    Article  CAS  PubMed  Google Scholar 

  22. Shen B, Remzi FH, Nutter B, et al.: Association between Immune-associated disorders and adverse outcomes of Ileal pouch-anal anastomosis. Am J Gastroenterol 2009, 104:655–664.

    Article  PubMed  Google Scholar 

  23. • Shen B, Plesec TP, Remer E, et al.: Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis 2010, 16:836–846. This article provides a description of ischemic pouchitis as a new disease entity.

    Article  PubMed  Google Scholar 

  24. Shen B, Bennett AE, Fazio VW, et al.: Collagenous pouchitis. Dig Liver Dis 2006, 38:704–709.

    Article  CAS  PubMed  Google Scholar 

  25. Shen B, Fazio VW, Bennett AE, et al.: Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch. Dig Dis Sci 2007, 52:3321–3328.

    Article  CAS  PubMed  Google Scholar 

  26. Sandborn WJ: Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In Trends in Inflammatory Bowel Disease 1996. Edited by McLeod RS, Martin F, Sutherland LR, et al. Lancaster, UK: Kluwer Academic Publishers; 1997:51–63.

    Google Scholar 

  27. Shen L, Lian L, Goldblum JR, Remzi FH: Development of de novo celiac disease after restorative proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2009, 15:1131–1132.

    Article  PubMed  Google Scholar 

  28. • Navaneethan U, Shen B: Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol 2009, 3:547–359. This article provides a comprehensive review of risks and benefits of antibiotic use in pouchitis.

    Article  CAS  PubMed  Google Scholar 

  29. Heuschen UA, Allemeyer EH, Hinz G, et al.: Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum 2002, 45:776–786.

    Article  PubMed  Google Scholar 

  30. Shen B, Pardi DS, Bennett AE, et al.: The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol 2009, 104:1468–1474.

    Article  CAS  PubMed  Google Scholar 

  31. •• Pardi DS, D’Haens G, Shen B, et al.: Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009, 15:1424–1431. The authors present the only available guidelines on management of pouchitis.

    Article  PubMed  Google Scholar 

  32. Shen B, Achkar J-P, Lashner BA, et al.: Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261–267.

    Article  CAS  PubMed  Google Scholar 

  33. Shen B, Achkar JP, Connor JT, et al.: Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748–753.

    Article  PubMed  Google Scholar 

  34. Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994, 69:409–415.

    CAS  PubMed  Google Scholar 

  35. Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167–174.

    Article  CAS  PubMed  Google Scholar 

  36. Shen B, Shermock KM, Fazio VW, et al.: A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2003, 98:2460–2467.

    PubMed  Google Scholar 

  37. Lohmuller JL, Pemberton HJ, Dozois RR, et al.: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990, 211:622–629.

    CAS  PubMed  Google Scholar 

  38. Wolf JM, Achkar JP, Lashner BA, et al.: Afferent limb ulcers predict Crohn’s disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1686–1691.

    Article  PubMed  Google Scholar 

  39. Apel R, Cohen Z, Andrews CW Jr, et al.: Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology 1994, 107:435–443.

    CAS  PubMed  Google Scholar 

  40. Veress B, Reinholt FP, Lindquist K, et al.: Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995, 109:1090–1097.

    Article  CAS  PubMed  Google Scholar 

  41. Pardi DS, Sandborn WJ: Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006, 23:1087–1096.

    Article  CAS  PubMed  Google Scholar 

  42. Navaneethan U, Shen B: Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. Am J Gastroenterol 2009, 104:2606–2615.

    Article  PubMed  Google Scholar 

  43. Kuisma J, Nuutinen H, Luukkonen P, et al.: Long term metabolic consequences of ileal pouch–anal anastomosis for ulcerative colitis. Am J Gastroenterol 2001, 96:3110–3116.

    CAS  PubMed  Google Scholar 

  44. M’koma AE: Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis 2006, 21:711–720.

    Article  PubMed  Google Scholar 

  45. Lu H, Lian L, Navaneethan U, Shen B: Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis. Inflamm Bowel Dis 2010 (Epub ahead of print).

    Google Scholar 

  46. Walkowiak J, Banasiewicz T, Krokowicz P, et al.: Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005, 40:1493–1494.

    Article  CAS  PubMed  Google Scholar 

  47. Johnson MW, Maestranzi S, Duffy AM, et al.: Fecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 2008, 20:174–179.

    Article  PubMed  Google Scholar 

  48. Parsi M, Shen B, Achkar J, et al.: Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1280–1286.

    Article  PubMed  Google Scholar 

  49. Lim M, Gonsalves S, Thekkinkattil D, et al.: The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. Dis Colon Rectum 2008, 51:96–99.

    Article  PubMed  Google Scholar 

  50. Melmed GY, Fleshner PR, Bardakcioglu O, et al.: Family history and serology predict Crohn’s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008, 51:100–108.

    Article  PubMed  Google Scholar 

  51. Tang L, Boone J, Moore L, et al.: Clinical significance of stool ASCA in disorders of the ileal pouch [abstract]. Inflamm Bowel Dis 2008, 12: S2.

    Google Scholar 

  52. Shen B: Campylobacter infection in patients with ileal pouches. Am J Gastroenterol 2010, 105:472–473.

    Article  PubMed  Google Scholar 

  53. • McLaughlin SD, Clark SK, Shafi S, et al.: Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. Clin Gastroenterol Hepatol 2009, 7:545–548. This article describes the first study to report the use of fecal coliform testing for treating patients with antibiotic-resistant pouchitis.

    Article  PubMed  Google Scholar 

  54. Seggerman RE, Chen MY, Waters GS, Ott DJ: Radiology of ileal pouch-anal anastomosis surgery. AJR Am J Roentgenol 2003, 180:999–1002.

    PubMed  Google Scholar 

  55. Shen B, Fazio VW, Remzi FH, et al.: Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005, 100:93–101.

    Article  PubMed  Google Scholar 

  56. Shepherd NA, Hulten L, Tytgat GN, et al.: Workshop: pouchitis. Int J Colorectal Dis 1989, 4:205–229.

    Article  CAS  PubMed  Google Scholar 

  57. Sagar PM, Pemberton JH: Ileo-anal pouch function and dysfunction. Dig Dis 1997, 15:172–188.

    Article  CAS  PubMed  Google Scholar 

  58. Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193–1196.

    Article  CAS  PubMed  Google Scholar 

  59. Shen B, Achkar JP, Lashner BA, et al.: A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001, 7:301–305.

    Article  CAS  PubMed  Google Scholar 

  60. Pepin J, Saheb N, Coulombe MA, et al.: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254–1260.

    Article  CAS  PubMed  Google Scholar 

  61. Isaacs KL, Sandler RS, Abreu M, et al.: Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007, 13:1250–1255.

    Article  PubMed  Google Scholar 

  62. Shen B, Remzi FH, Lopez AR, Queener E: Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol 2008, 8:26.

    Article  PubMed  Google Scholar 

  63. Shen B, Fazio V, Remzi F, et al.: Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Col Rectum 2007, 50:498–508.

    Article  Google Scholar 

  64. • Ha CY, Bauer JJ, Lazarev M, et al.: Early institution of tinidazole may prevent pouchitis following ileal-pouch anal anastomosis (IPAA) surgery in ulcerative colitis (UC) patients [abstract]. Gastroenterology 2010, 138:S69. The authors describe a randomized, controlled trial of tinidazole in preventing pouchitis after IPAA surgery.

    Google Scholar 

  65. Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202–1209.

    Article  PubMed  Google Scholar 

  66. Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305–309.

    Article  CAS  PubMed  Google Scholar 

  67. Elahi B, Nikfar S, Derakhshani S, et al.: On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2008, 53:1278–1284.

    Article  PubMed  Google Scholar 

  68. Shen B, Remzi FH, Lavery IC, et al.: Administration of adalimumab in the treatment of Crohn’s disease of the ileal pouch. Aliment Pharmacol Ther 2009, 29:519–526.

    Article  CAS  PubMed  Google Scholar 

  69. Wischmeyer P, Pemberton JH, Phillips SF: Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993, 68:978–981.

    CAS  PubMed  Google Scholar 

  70. Tremaine WJ, Sandborn WJ, Wolff BG, et al.: Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997, 11:1041–106.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

Conflicts of interest: Dr. Navaneethan: none. Dr. Shen reported grants or grants pending to his institution from Ocera Therapeutics.

Author information

Authors and Affiliations

  1. The Pouchitis Clinic, Digestive Disease Institute, The Cleveland Clinic Foundation, Desk A31, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Udayakumar Navaneethan & Bo Shen

Authors
  1. Udayakumar Navaneethan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bo Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Shen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navaneethan, U., Shen, B. Diagnosis and Management of Pouchitis and Ileoanal Pouch Dysfunction. Curr Gastroenterol Rep 12, 485–494 (2010). https://doi.org/10.1007/s11894-010-0143-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-010-0143-y

Keywords

Search

Navigation